Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
表面蛋白质组学揭示 CD72 是 KMT2A/MLL1 重排 B-ALL 中体外进化的基于纳米抗体的 CAR-T 细胞的靶标
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-20-0242
Matthew A Nix, Kamal Mandal, Huimin Geng, Neha Paranjape, Yu-Hsiu T Lin, Jose M Rivera, Makeba Marcoulis, Kristie L White, Jeffrey D Whitman, Sagar P Bapat, Kevin R Parker, Jonathan Ramirez, Anne Deucher, Paul Phojanokong, Veronica Steri, Faranak Fattahi, Byron C Hann, Ansuman T Satpathy, Aashish Ma